Home/Filings/4/0001860253-26-000002
4//SEC Filing

Rau Diogo 4

Accession 0001860253-26-000002

CIK 0000059478other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 4:28 PM ET

Size

8.1 KB

Accession

0001860253-26-000002

Research Summary

AI-generated summary of this filing

Updated

Eli Lilly (LLY) EVP Diogo Rau Exercises RSUs, Sells Shares for Taxes

What Happened

  • Diogo Rau, EVP & Chief Information and Digital Officer at Eli Lilly (LLY), had 3,752 restricted stock units (RSUs) convert to common shares on 2026-02-01. To satisfy tax withholding, 1,673.538 shares were disposed at $1,037.15 per share, raising $1,735,710. The conversion and the withholding/sale were reported on a Form 4 filed 2026-02-03.
  • Net of the withholding, Rau retained approximately 2,078.462 shares from this vesting event (3,752 converted minus 1,673.538 withheld).

Key Details

  • Transaction date: 2026-02-01; Form 4 filed: 2026-02-03 (timely).
  • Conversion (code M): 3,752 RSUs converted to common shares @ $0.00 (reported as acquisition).
  • Tax withholding/disposition (code F): 1,673.538 shares disposed @ $1,037.15 = $1,735,710.
  • Ownership after transaction: not specified in the filing summary (filing shows the conversion and withholding, but does not list total holdings here).
  • Footnote: Each restricted stock unit represents the contingent right to one share of Eli Lilly common stock (F1).
  • Transaction codes: M = exercise/conversion of a derivative (here, RSU vesting); F = payment of exercise price or tax liability (share withholding/sale).

Context

  • This appears to be a routine RSU vesting with net settlement for taxes (shares withheld/sold to cover tax liability), not an open-market investment decision. Such tax-withholding dispositions are common when equity awards vest and do not necessarily indicate a view on the company’s stock.

Insider Transaction Report

Form 4
Period: 2026-02-01
Rau Diogo
EVP & CIDO
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-01+3,75223,470.908 total
  • Tax Payment

    Common Stock

    2026-02-01$1037.15/sh1,673.538$1,735,71021,797.37 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F1]
    2026-02-013,7520 total
    From: 2026-02-01Exp: 2026-02-01Common Stock (3,752 underlying)
Footnotes (1)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Signature
/s/ Jonathan Groff for Diogo Rau, pursuant to authorization on file|2026-02-03

Issuer

ELI LILLY & Co

CIK 0000059478

Entity typeother

Related Parties

1
  • filerCIK 0001860253

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:28 PM ET
Size
8.1 KB